News

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
A federal vaccine advisory panel voted this week to recommend significant updates to the nation’s respiratory syncytial virus (RSV) and influenza vaccination policies, signaling a new direction ...
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Concerns raised by University of Minnesota’s Dr. David Boulware correct record before a federal vaccine advisory committee ...
The newly appointed members of the CDC’s influential vaccine committee meet Wednesday and Thursday under an unusually rapid ...